ISO/TC 212
Registration number (WIID) | Project No. | Title | Status |
---|---|---|---|
72191 | ISO 15190:2020 | Medical laboratories — Requirements for safety | Standarts spēkā |
71293 | ISO 35001:2019 | Biorisk management for laboratories and other related organisations | Standarts spēkā |
69803 | ISO 20166-3:2018 | Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for formalin-fixed and paraffin-embedded (FFPE) tissue — Part 3: Isolated DNA | Standarts spēkā |
88418 | ISO 35001:2019/Amd 1:2024 | Biorisk management for laboratories and other related organisations — Amendment 1: Climate action changes | Standarts spēkā |
54976 | ISO 15197:2013 | In vitro diagnostic test systems — Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus | Standarts spēkā |
69799 | ISO 20186-2:2019 | Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for venous whole blood — Part 2: Isolated genomic DNA | Standarts spēkā |
54868 | ISO 23640:2011 | In vitro diagnostic medical devices — Evaluation of stability of in vitro diagnostic reagents | Standarts spēkā |
79379 | ISO 16256:2021 | Clinical laboratory testing and in vitro diagnostic test systems — Broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against yeast fungi involved in infectious diseases | Standarts spēkā |
87680 | ISO/TS 22583:2024 | Requirements and recommendations for supervisors and operators of point-of-care testing (POCT) equipment | Standarts spēkā |
67215 | ISO 20184-1:2018 | Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for frozen tissue — Part 1: Isolated RNA | Standarts spēkā |
Displaying 31-40 of 142 results.